| NCT ID | NCT03611556 |
| Title | MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | MedImmune LLC |
| Indications | |
| Therapies |
Gemcitabine + Nab-paclitaxel + Oleclumab Durvalumab + Gemcitabine + Nab-paclitaxel + Oleclumab Fluorouracil + Leucovorin + Oxaliplatin Fluorouracil + Leucovorin + Oleclumab + Oxaliplatin Durvalumab + Fluorouracil + Leucovorin + Oleclumab + Oxaliplatin |
| Age Groups: | adult senior |